ReachMD: The importance of extended genotyping in cervical cancer screening: The special case of HPV 31

Could an HPV test with extended genotyping that can individually identify HPV 16, 18, 31, and other genotypes change the way we manage cervical cancer screening results?

In this video, Dr. Mark Stoler, Professor of Pathology and Clinical Gynecology at the University of Virginia Health System, discusses the special case of HPV 31.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Women in boat
Cervical Cancer | News & Updates
Press Release: New Survey by The Harris Poll Highlights Gaps in Cervical Cancer Screening Access
Original research: Performance of a vaginal panel assay compared with the clinical diagnosis of vaginitis
Original research: Performance of a vaginal panel assay compared with the clinical diagnosis of vaginitis
Cervical Cancer Screening: The Current State of Testing
Cervical Cancer | Articles & Publications
Cervical Cancer Screening: The Current State of Testing